[8-K] Procter & Gamble Company Reports Material Event

Rhea-AI Filing Summary

0000080424FalseFalse00000804242025-07-292025-07-290000080424us-gaap:CommonStockMember2025-07-292025-07-290000080424exch:XNYS2025-07-292025-07-290000080424pg:A0.110NotesDue2026Domain2025-07-292025-07-290000080424pg:A3.25EURNotesDue2026Domain2025-07-292025-07-290000080424pg:A4.875EURNotesDueMay2027Domain2025-07-292025-07-290000080424pg:A1.200NotesDue2028Domain2025-07-292025-07-290000080424pg:A3.150EURNotesDue2028Domain2025-07-292025-07-290000080424pg:A1.250NotesDue2029Domain2025-07-292025-07-290000080424pg:A1.800NotesDue2029Domain2025-07-292025-07-290000080424pg:A6.250GBPNotesDueJanuary2030Domain2025-07-292025-07-290000080424pg:A0.350NotesDue2030Domain2025-07-292025-07-290000080424pg:A0.230NotesDue2031Domain2025-07-292025-07-290000080424pg:A3.250EURNotesDue2031Domain2025-07-292025-07-290000080424pg:A5.250GBPNotesDueJanuary2033Domain2025-07-292025-07-290000080424pg:A3.200EURNotesDue2034Domain2025-07-292025-07-290000080424pg:A1.875NotesDue2038Domain2025-07-292025-07-290000080424pg:A0.900NotesDue2041Domain2025-07-292025-07-29

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________________

FORM 8-K

___________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): 7/29/2025

___________________________________

The Procter & Gamble Company

(Exact name of registrant as specified in its charter)

___________________________________

Ohio (State or other jurisdiction of incorporation or organization)			001-00434 (Commission File Number)			31-0411980 (I.R.S. Employer Identification Number)
One Procter & Gamble Plaza Cincinnati, Ohio 45202
(Address of principal executive offices and zip code)
(513) 983-1100
(Registrant's telephone number, including area code)

___________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class			Trading Symbol			Name of each exchange on which registered
Common Stock without Par Value			PG			NYSE
0.110% Notes due 2026			PG26D			NYSE
3.25% EUR Notes due 2026			PG26F			NYSE
4.875% EUR Notes due May 2027			PG27A			NYSE
1.200% Notes due 2028			PG28			NYSE
3.150% EUR Notes due 2028			PG28B			NYSE
1.250% Notes due 2029			PG29B			NYSE
1.800% Notes due 2029			PG29A			NYSE
6.250% GBP Notes due January 2030			PG30			NYSE
0.350% Notes due 2030			PG30C			NYSE
0.230% Notes due 2031			PG31A			NYSE
3.250% EUR Notes due 2031			PG31B			NYSE
5.250% GBP Notes due January 2033			PG33			NYSE
3.200% EUR Notes due 2034			PG34C			NYSE
1.875% Notes due 2038			PG38			NYSE
0.900% Notes due 2041			PG41			NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.

Emerging growth company    ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 7.01 - Regulation FD Disclosure

On July 29, 2025, The Procter & Gamble Company (the "Company") issued a press release announcing its fourth quarter and fiscal year 2025 results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website.

This 8-K is being furnished pursuant to Item 7.01, "Regulation FD Disclosure."

Item 9.01 - Financial Statements and Exhibits

(d): The following exhibits are being filed herewith:

Exhibit No.						Description
99.1						Informational Slides Provided by The Procter & Gamble Company dated July 29, 2025.
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 29th day of July, 2025.

THE PROCTER & GAMBLE COMPANY
By:			/s/ Sandra T. Lane
Name:			Sandra T. Lane
Title:			Assistant Secretary

INDEX TO EXHIBIT(S)

99.1 - Informational Slides Provided by The Procter & Gamble Company dated July 29, 2025.

FAQ

What information is available?

This document appears to contain limited substantive content.